Jubak Pick SolarEdge beat on earnings yesterday, gains 23% today
SolarEdge Technologies (SEDG) reported earnings of 64 cents a share after the New York markets closed yesterday. That was 7 cents a share above Wall Street projections. The company reported first quarter revenue of $271.9 million, up 29.5% year over year, and ahead of...
Adding Dollar General to my Jubak Picks Portfolio
At a moment when all of brick and mortar retailing can seem to be suffering, Dollar General (DG) has announced that it will open 975 new stores in 2019 and remodel 1,000 existing stores. For 2019 capital expenditures are projected at $775 million to $825 million or...
I said I’d sell CTRP on first sign that upward momentum had broken–well, I’m selling today
Yesterday I posted that I would sell Ctrip International.com out of my Jubak Picks portfolio at the first sign that the stock’s upward momentum had broken. Well, the New York traded ADS for Ctrip closed down 5.42% today. I think that counts as a break and...
Is the next big tech stock thing, Chinese tech stocks?
There’s some evidence that the money that has left big U.S. tech stocks such as Facebook (FB), Netflix (NFLX), Microsoft (MSFT) and Amazon (AMZN) on some recent days has been headed into big Chinese tech stocks such as Tencent Holdings (TCEHY), Alibaba (BABA),...
Raising target price on Danaher after earnings beat today
Danaher (DHR) reported fourth quarter earnings of 80 cents a share before the market opened today, April 19. That was 3 cents a share ahead of Wall Street projections. Revenue climbed 10.9% year over year to $5.09 billion. The Wall Street consensus called for $4.97...
Oil prices up again on inventories, Middle East fears, OPEC price goals
West Texas Intermediate crude climbed 3.16% today to $68.80 a barrel. Futures for May delivery moved over $68 a barrel for the first time in three years. Yesterday the American Petroleum Institute reported a 1.05 million barrel draw down in U.S. inventories. Today the...Goldman Sachs turns bullish on gold
Goldman Sachs has turned positive on gold for the first time in five years. Â “Our commodities team believes that the dislocation between the gold prices and U.S. rates is here to say,” Goldman Sachs says. Drivers for higher gold prices include signs of an...
Selling Boeing shares on the President’s tariff announcement
I don’t think there’s any point to waiting around to see how quickly or fiercely China (and the European Union) will retaliate against U.S. exporters after today’s announcement that the United States will put a 25% tariff on Chinese (and other...
Big earnings report from MGM Resorts before the market open tomorrow
Tomorrow’s earnings report from MGM Resorts International (MGM) could be make or break for the call options that I hold on this stock in my Volatility Portfolio. The options have been all over the block in recent weeks from up 50% to down 30% on market...
Nektar soars today on J.P. Morgan healthcare conference
Anybody still think that conferences, especially biotech conferences, don’t move stock prices? Shares of Nektar Therapeutics (NKTR) are up 7.65% today to $61.79 as of noon New York time on the company’s appearance at this week’s J.P. Morgan biotech...
Autoliv earnings: So when is the future?
On October 26 Autoliv (ALV) reported third quarter earnings of $1.47 a share, 12 cents a share above the Wall Street consensus. Revenue climbed just 1.6% year over year to match the analyst projection at $2.5 billion. Â The problem in the quarter was revenue...
Synaptics reports earnings: So how’s that transition going?
Synaptics (SYNA) announced September quarter (first fiscal 2018 quarter) earnings after the market close on November 7. Earnings of $1.03 a share were 7 cents a share above the Wall Street consensus. Revenue climbed 8.1% year over year to $417 million against the $399...
Alibaba plans to use Singles’ Day shopping frenzy to lock in market dominance for years
Alibaba (BABA) generated $1 billion in gross merchandise volume in just the first three minutes of the Singles’ Day shopping event in China today. By the end of two hours the sales volume was just shy of $12 billion. The company’s Alibaba Cloud unit...
Visa beats on earnings and revenue as payment volumes climb by 9.8%
Today October 25 Visa (V) reported September quarter earnings of 90 cents a share, 5 cents a share above Wall Street projections. Revenue climbed 13.9% year over year to $4.86 billion vs. Wall Street projections of $4.63 billion. Â Payments volume, on a constant...
Jubak Picks Danaher reports breakout quarter
On October 16 Jubak Picks Danaher (DHR) reported third quarter earnings of $1.00 a share, five cents a share above Wall Street expectations. Revenue grew by 9.7% year over year to $4.53 billion, above Wall Street projections of $4.47 billion. The company raised its...
I’m buying China’s online travel leader CTRP for my Jubak Picks portfolio today
There are three things to think about before buying Ctrip.com International (CTRP), the leader in China’s online travel market. Two of these things are positive and one negative. I think the balance comes down on the positive side but the negative element means...
Some signs the bottom is in for Incyte
This qualifies as a horrendous six months for any stock: Shares of Incyte (INCY) are down from $152.66 on March 15 to $115.19 at the close today, October 2. The shares have been even lower, which is one thing giving me some hope that the pain is coming to an end. The...
Xylem raises guidance for fiscal 2017 after slight earnings beat in second quarter
On August 1 Xylem (XYL) reported second quarter earnings of 59 cents a share (excluding one-time items), beating Wall Street earnings estimates by 2 cents a share. Thanks to recent acquisitions revenue of $1.16 billion climbed 24.9% year over year, slightly missing...
Financial markets decide the S&P earnings recession is over–time to sell my S&P short ETF
It looks like the third quarter saw the end of the long earning recession for Standard & Poor’s 500 companies. That recession had seen earnings for the S&P 500 companies drop for five straight quarters. With more than 90% of the S&P 500 companies...
Bristol-Myers continues to make up lost ground after August failure of Opdivo trial
Back on August 8 Bristol-Myers Squibb (BMY) announced that its key immuno-oncology drug Opdivo had failed to demonstrate its efficacy in a trial for treating lung cancer. At the time I characterized this particular trial as a part of a go-for-broke strategy that would...
Catching up on performance reporting: Jubak Picks up 4.91% in 2014
I’ve never liked doing all the calculations required to figure out the performance of my Jubak’s Picks portfolio. Frankly, figuring out the exact gains in positions that have, because of history, come to have radically different numbers of shares and then...Jubak’s Picks Performance: 2011 down 2.3%; yearend cash reaches 37%
The Jubak’s Picks, my 12-18 month portfolio, lost 2.3% for 2011. That trailed the 2.1% return for the Standard & Poor’s 500 Index during the year. The problem for the portfolio was my inability to stay nimble enough to navigate the market’s volatility in 2011. Or...Adding Autoliv to my Jubak Picks portfolio as earnings report confirms growth story
April 29th, 2016 When back on March 29 I gave a thumbs up to Autoliv (ALV) in a post on my subscription JubakAM.com site as a pick for the increasing automaker emphasis upon safety and driver-assisted or autonomous driving systems, I said I’d like to wait until after...Adding Autoliv to my Jubak Picks portfolio as earnings report confirms growth story
When back on March 29 I gave a thumbs up to Autoliv (ALV) in a post on my subscription JubakAM.com site as a pick for the increasing automaker emphasis upon safety and driver-assisted or autonomous driving systems, I said I’d like to wait until after the company’s...Buy Westpac Banking (WBK)
They have banks in Australia too. And a stronger economy and an appreciating currency against the U.S. dollar. And no government constraints on raising dividends if a bank wants to signal its confidence in the future. I’m going to use the weakness in Australian stocks...Update Ambev (ABV)
Every quarter I think that the run in shares of AmBev (ABV) might be over. After all the stock is up 42% in 2010 as of November 8. But then the company does something to surprise me. And I decide that it’s worth staying on board. This time, the company said on...Sell Middleby (MIDD)
I’ve owned Middleby (MIDD) in my Jubak’s Picks portfolio since May 20, 2008 and I think it’s now time to take some profits. Nothing unusual about these shares. And that’s exactly the point. At this stage of the rally I’d like to keep close watch on valuations and sell...Update Middleby (MIDD)
Has Middleby (MIDD) finally moved off the back burner? Middleby’s shares were up 29% from February 8 through March 5, and the relative strength on the stock has moved to 72 for the last three months from 56 over the last six months. (Relative strength measures how a...Update Marvell Technology Group (MRVL)
After the market closed yesterday (March 4) Marvell Technology Group (MRVL) reported fourth quarter fiscal 2010 earnings of 40 cents a share (excluding items). That was 3 cents a share above the official Wall Street consensus. Revenue climbed 64% from the fourth...Jim’s Daily Email Alerts:
Every post from Jubak Picks straight to your mailbox. And they're free!